B Heppy

Bright and Evangeline sit down with Shaibu Issa, a dedicated hepatitis B advocate from Tanzania. We talk about his story with hepatitis B from losing his brother, feeling ostracized from his community, to now raising awareness and spreading information about hepatitis B. Listen more for his story. Support the showOur website: www.hepb.orgSupport B Heppy!Social Media: Instagram - Twitter - Facebook

In part II of our stigma series, we sit down with Chris Munoz of the Yellow Warriors Society in the Phillippines to talk about their hepatitis B work and what he has see related to hepatitis B stigma and discrimination. Yellow Warriors SocietySupport the showOur website: www.hepb.orgSupport B Heppy!Social Media: Instagram - Twitter - Facebook

On this episode, we get to talk with Danjuma Adda, CEO of TY Danjuma Foundation and current World Hepatitis Alliance President to talk about his experience with viral hepatitis B, hepatitis B related stigma, and his efforts to improve the quality of life for individuals living with hepatitis B. Listen for more. World Hepatitis Alliance TY Danjuma FoundationSupport the showOur website: www.hepb.orgSupport B Heppy!Social Media: Instagram - Twitter - Facebook

Evangeline and Bright chat with Dr. Jessie Torgersen from Penn Medicine to talk about hepatitis B treatment: when to start, can I stop, what medicines are available to me, and more. Support the showOur website: www.hepb.orgSupport B Heppy!Social Media: Instagram - Twitter - Facebook

Bright and Evangeline sit down with Dan to talk about his experience with hepatitis Delta. We talk about his initial feelings surrounding the diagnosis, his treatment, how he got involved with the Hepatitis B Foundation, and his hope for the future of all people living with hepatitis B and Delta. More about hepatitis DeltaHep B CommunityClinical Trials FinderSupport the showOur website: www.hepb.orgSupport B Heppy!Social Media: Instagram - Twitter - Facebook

In this episode Evangeline and Bright discuss questions you should ask your doctor regarding your hepatitis B status. This episode is intended to prompt our listeners to take charge of their health and be their own advocate while at a doctor's appointment.  Support the showOur website: www.hepb.orgSupport B Heppy!Social Media: Instagram - Twitter - Facebook

Listen to this special episode hosted by Ed Tate, Director of Communications at the Hepatitis B Foundation. He was able to interview esteemed scientists and researchers from the 2022 HBV Meeting in Paris to discuss their hepatitis B related work. He gives insight on what new research is coming out about hepatitis B. Support the showOur website: www.hepb.orgSupport B Heppy!Social Media: Instagram - Twitter - Facebook

On this episode B Heppy we sit down with Dr. Mike Sofia, Co-founder and Chief Scientific Officer at Arbutus Biopharma to talk about his company's work on hepatitis B curative therapies. Listen and learn more about the pre-clinical process.  Resources:Arbutus BiopharmaDrug Watch Clinical Trial Finder Support the showOur website: www.hepb.orgSupport B Heppy!Social Media: Instagram - Twitter - Facebook

October is Liver Cancer Awareness Month. As we wrap up the month, we present a special episode from the 2022 HBV Meeting in Paris.  Ed Tate, Director of Communications and Marketing at the Hepatitis B Foundation was able to interview Dr. Mathias Heikenwalder to talk about updates on liver cancer research. For more information on liver cancer you can go to Liver Cancer Connect. Support the showOur website: www.hepb.orgSupport B Heppy!Social Media: Instagram - Twitter - Facebook

This episode discusses #justB Storyteller's David's mental health journey within his hepatitis B diagnosis. We talk about experiencing fears related to hepatitis B and how David empowered himself after those initial scary feelings. Listen for more. Watch his story here: www.hepb.org/research-and-programs/patient-story-telling-project/davids-story/Resources here: https://www.hepbcommunity.org/Support the showOur website: www.hepb.orgSupport B Heppy!Social Media: Instagram - Twitter - Facebook